MLYS icon

Mineralys Therapeutics

108 hedge funds and large institutions have $572M invested in Mineralys Therapeutics in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 44 increasing their positions, 17 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

2% more funds holding

Funds holding: 106108 (+2)

0% more funds holding in top 10

Funds holding in top 10: 77 (0)

88% less call options, than puts

Call options by funds: $1K | Put options by funds: $8K

Holders
108
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
$8K
Net Calls
Net Calls Change

Top Buyers

1 +$12.3M
2 +$6.39M
3 +$5.94M
4
SC
Stempoint Capital
New York
+$4.93M
5
Jennison Associates
Jennison Associates
New York
+$4.75M

Top Sellers

1 -$7.27M
2 -$4.96M
3 -$4.82M
4
BOCH
Blue Owl Capital Holdings
New York
-$2.38M
5
Ensign Peak Advisors
Ensign Peak Advisors
Utah
-$1.51M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$4.31M
27
$4.09M
28
$3.76M
29
$3.74M
30
$3.03M
31
$2.65M
32
$2.35M
33
$1.8M
34
$1.69M
35
$1.55M
36
$1.47M
37
$1.38M
38
$1.33M
39
$1.22M
40
$1.13M
41
$1.1M
42
$1.1M
43
$972K
44
$836K
45
$804K
46
$602K
47
$571K
48
$499K
49
$495K
50
$346K